📖
Heterogeneity in the treatment effect of sodium-glucose cotransporter-2 inhibitor on chronic kidney disease risk reduction: a prevalent new user cohort study applying double/debiased machine learning.
Kongmalai T, Looareesuwan P, Tansawet A, Siriyotha S, Kunakorntham P, Boonwatcharapai B, Attia J, McKay GJ, Thakkinstian A

Heterogeneity in the treatment effect of sodium-glucose cotransporter-2 inhibitor on chronic kidney disease risk reduction: a prevalent new user cohort study applying double/debiased machine learning.

Medicine & Health Published 2026 Verification Pending

Overview & Synopsis

Open access biomedical research article published in Diabetol Metab Syndr.

Indexed from repository: PubMed Central (pmc.ncbi.nlm.nih.gov)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title Heterogeneity in the treatment effect of sodium-glucose cotransporter-2 inhibitor on chronic kidney disease risk reduction: a prevalent new user cohort study applying double/debiased machine learning.
Author / Organization Kongmalai T, Looareesuwan P, Tansawet A, Siriyotha S, Kunakorntham P, Boonwatcharapai B, Attia J, McKay GJ, Thakkinstian A
Subject & Discipline Diabetol Metab Syndr
Categories Medicine & Health
Publication Year 2026
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website PubMed Central (pmc.ncbi.nlm.nih.gov)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-61189
Original Source Link Visit Source Page on pmc.ncbi.nlm.nih.gov »